Salivary cortisol in depressed patients versus control persons: A systematic review and meta-analysis

Psychoneuroendocrinology

Volumn 35, Issue 9, 2010, Pages 1275-1286

  Knorr, Ulla ^a   Vinberg, Maj ^a   Kessing, Lars V ^a   Wetterslev, Jørn ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Control persons; Cortisol; Depression; Meta analysis; Saliva; Systematic review

Indexed keywords

HYDROCORTISONE;

AGING; BIPOLAR DEPRESSION; CASE CONTROL STUDY; CIRCADIAN RHYTHM; CLINICAL TRIAL; DEPRESSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFORMATION RETRIEVAL; META ANALYSIS; MOOD DISORDER; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REVIEW; SALIVA ANALYSIS; SALIVA LEVEL; SYSTEMATIC REVIEW;

ALGORITHMS; BIAS (EPIDEMIOLOGY); CASE-CONTROL STUDIES; DEPRESSION; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, ENDOCRINE; HUMANS; HYDROCORTISONE; PATIENTS; SALIVA;

EID: 77957727502     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2010.04.001     Document Type: Review

References (54)

1. Adam E.K., Kumari M. Assessing salivary cortisol in large-scale, epidemiological research. Psychoneuroendocrinology 2009, 34:1423-1436.
2. Alhaj H.A., Massey A.E., Allister-Williams R.H. A study of the neural correlates of episodic memory and HPA axis status in drug-free depressed patients and healthy controls. J. Psychiatry Res. 2007, 41:295-304.
3. Altman D.G., Bland J.M. Interaction revisited: the difference between two estimates. BMJ 2003, 326:219.
4. Assies J., Visser I., Nicolson N.A., Eggelte T.A., Wekking E.M., Huyser J., Lieverse R., Schene A.H. Elevated salivary dehydroepiandrosterone-sulfate but normal cortisol levels in medicated depressed patients: preliminary findings. Psychiatry Res. 2004, 128:117-122.
5. Bauer M.E., Papadopoulos A., Poon L., Perks P., Lightman S.L., Checkley S., Shanks N. Dexamethasone-induced effects on lymphocyte distribution and expression of adhesion molecules in treatment-resistant depression. Psychiatry Res. 2002, 113:1-15.
6. Bhagwagar Z., Hafizi S., Cowen P.J. Increased salivary cortisol after waking in depression. Psychopharmacology (Berl) 2005, 182:54-57.
7. Bhagwagar Z., Hafizi S., Cowen P.J. Increase in concentration of waking salivary cortisol in recovered patients with depression. Am. J. Psychiatry 2003, 160:1890-1891.
8. Colomina M.T., Canals J., Carbajo G., Domingo J.L. Salivary cortisol in a young population: relationship with psychopathological disorders. Res. Commun. Biol. Psychol. Psychiatry 1997, 22:1-10.
9. Copolov D.L., Rubin R.T., Stuart G.W., Poland R.E., Mander A.J., Sashidharan S.P., Whitehouse A.M., Blackburn I.M., Freeman C.P., Blackwood D.H. Specificity of the salivary cortisol dexamethasone suppression test across psychiatric diagnoses. Biol. Psychiatry 1989, 25:879-893.
10. den Hartog H.M., Nicolson N.A., Derix M.M., van Bemmel A.L., Kremer B., Jolles J. Salivary cortisol patterns and cognitive speed in major depression: a comparison with allergic rhinitis and healthy control subjects. Biol. Psychol. 2003, 63:1-14.
11. Deshauer D., Duffy A., Meaney M., Sharma S., Grof P. Salivary cortisol secretion in remitted bipolar patients and offspring of bipolar parents. Bipolar. Disord. 2006, 8:345-349.
12. Dockray S., Bhattacharyya M.R., Molloy G.J., Steptoe A. The cortisol awakening response in relation to objective and subjective measures of waking in the morning. Psychoneuroendocrinology 2008, 33:77-82.
13. Edwards S., Evans P., Hucklebridge F., Clow A. Association between time of awakening and diurnal cortisol secretory activity. Psychoneuroendocrinology 2001, 26:613-622.
14. Egger M., Smith G.D., Phillips A.N. Meta-analysis: principles and procedures. BMJ 1997, 315:1533-1537.
15. Galard R., Catalan R., Castellanos J.M., Gallart J.M. Plasma corticotropin-releasing factor in depressed patients before and after the dexamethasone suppression test. Biol. Psychiatry 2002, 51:463-468.
16. Halligan S.L., Herbert J., Goodyer I., Murray L. Disturbances in morning cortisol secretion in association with maternal postnatal depression predict subsequent depressive symptomatology in adolescents. Biol. Psychiatry 2007, 62:40-46.
17. Halligan S.L., Herbert J., Goodyer I.M., Murray L. Exposure to postnatal depression predicts elevated cortisol in adolescent offspring. Biol. Psychiatry 2004, 55:376-381.
18. Hellhammer D.H., Wust S., Kudielka B.M. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology 2009, 34:163-171.
19. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, 21:1539-1558.
20. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000, 23:477-501.
21. Ising M., Horstmann S., Kloiber S., Lucae S., Binder E.B., Kern N., Kunzel H.E., Pfennig A., Uhr M., Holsboer F. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression-a potential biomarker?. Biol. Psychiatry 2007, 62:47-54.
22. Johannsen A., Rylander G., Soder B., Asberg M. Dental plaque, gingival inflammation, and elevated levels of interleukin-6 and cortisol in gingival crevicular fluid from women with stress-related depression and exhaustion. J. Periodontol. 2006, 77:1403-1409.
23. Juruena M.F., Cleare A.J., Papadopoulos A.S., Poon L., Lightman S., Pariante C.M. Different responses to dexamethasone and prednisolone in the same depressed patients. Psychopharmacology (Berl) 2006, 189:225-235.
24. Le M.M., Cowen P.J., Harmer C.J. Emotional bias and waking salivary cortisol in relatives of patients with major depression. Psychol. Med. 2007, 37:403-410.
25. Levine A., Zagoory-Sharon O., Feldman R., Lewis J.G., Weller A. Measuring cortisol in human psychobiological studies. Physiol. Behav. 2007, 90:43-53.
26. Mannie Z.N., Harmer C.J., Cowen P.J. Increased waking salivary cortisol levels in young people at familial risk of depression. Am. J. Psychiatry 2007, 164:617-621.
27. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D., Stroup D.F. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement, Quality of Reporting of Meta-analyses. Lancet 1999, 354:1896-1900.
28. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. J. Clin. Epidemiol. 2009, 62:1006-1012.
29. O'Brien J.T., Lloyd A., McKeith I., Gholkar A., Ferrier N. A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am. J. Psychiatry 2004, 161:2081-2090.
30. Peeters F., Nicholson N.A., Berkhof J. Cortisol responses to daily events in major depressive disorder. Psychosom. Med. 2003, 65:836-841.
31. Peeters F., Nicolson N.A., Berkhof J. Levels and variability of daily life cortisol secretion in major depression. Psychiatry Res. 2004, 126:1-13.
32. Pogue J., Yusuf S. Overcoming the limitations of current meta-analysis of randomised controlled trials. Lancet 1998, 351:47-52.
33. Pogue J.M., Yusuf S. Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. Control Clin. Trials 1997, 18:580-593.
34. Porter R.J., Gallagher P., Watson S., Smith M.S., Young A.H. Elevated prolactin responses to L-tryptophan infusion in medication-free depressed patients. Psychopharmacology (Berl) 2003, 169:77-83.
35. Reboussin D.M., DeMets D.L., Kim K.M., Lan K.K. Computations for group sequential boundaries using the Lan-DeMets spending function method. Control Clin. Trials 2000, 21:190-207.
36. Rosmalen J.G., Oldehinkel A.J., Ormel J., de Winter A.F., Buitelaar J.K., Verhulst F.C. Determinants of salivary cortisol levels in 10-12 year old children; a population-based study of individual differences. Psychoneuroendocrinology 2005, 30:483-495.
37. Stanton B.R., David A.S., Cleare A.J., Sierra M., Lambert M.V., Phillips M.L., Porter R.J., Gallagher P., Young A.H. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with depersonalization disorder. Psychiatry Res. 2001, 104:85-89.
38. Stetler C., Dickerson S.S., Miller G.E. Uncoupling of social zeitgebers and diurnal cortisol secretion in clinical depression. Psychoneuroendocrinology 2004, 29:1250-1259.
39. Strickland P.L., Deakin J.F., Percival C., Dixon J., Gater R.A., Goldberg D.P. Bio-social origins of depression in the community. Interactions between social adversity, cortisol and serotonin neurotransmission. Br. J. Psychiatry 2002, 180:168-173.
40. Thompson J.M., Gallagher P., Hughes J.H., Watson S., Gray J.M., Ferrier I.N., Young A.H. Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br. J. Psychiatry 2005, 186:32-40.
41. Treadway M.T., Grant M.M., Ding Z., Hollon S.D., Gore J.C., Shelton R.C. Early adverse events, HPA activity and rostral anterior cingulate volume in MDD. PLoS One 2009, 4:e4887.
42. Tsapakis E.M., Soldani F., Tondo L., Baldessarini R.J. Efficacy of antidepressants in juvenile depression: meta-analysis. Br. J. Psychiatry 2008, 193:10-17.
43. Vinberg M., Bennike B., Kyvik K.O., Andersen P.K., Kessing L.V. Salivary cortisol in unaffected twins discordant for affective disorder. Psychiatry Res. 2008, 161:292-301.
44. Vreeburg S.A., Hoogendijk W.J., van P.J., Derijk R.H., Verhagen J.C., van D.R., Smit J.H., Zitman F.G., Penninx B.W. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch. Gen. Psychiatry 2009, 66:617-626.
45. Watson S., Gallagher P., Del-Estal D., Hearn A., Ferrier I.N., Young A.H. Hypothalamic-pituitary-adrenal axis function in patients with chronic depression. Psychol. Med. 2002, 32:1021-1028.
46. Watson S., Gallagher P., Ritchie J.C., Ferrier I.N., Young A.H. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br. J. Psychiatry 2004, 184:496-502.
47. Weber-Hamann B., Hentschel F., Kniest A., Deuschle M., Colla M., Lederbogen F., Heuser I. Hypercortisolemic depression is associated with increased intra-abdominal fat. Psychosom. Med. 2002, 64:274-277.
48. Weibel L. Methodological guidelines for the use of salivary cortisol as biological marker of stress. Presse Med. 2003, 32:845-851.
49. Wetterslev J., Thorlund K., Brok J., Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC. Med. Res. Methodol. 2009, 9:86.
50. Wetterslev J., Thorlund K., Brok J., Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J. Clin. Epidemiol. 2008, 61:64-75.
51. Whiting P., Rutjes A.W., Reitsma J.B., Bossuyt P.M., Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med. Res. Methodol. 2003, 3:25.
52. Young A.H., Gallagher P., Porter R.J. Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients. Am. J. Psychiatry 2002, 159:1237-1239.
53. Young E.A., Aggen S.H., Prescott C.A., Kendler K.S. Similarity in saliva cortisol measures in monozygotic twins and the influence of past major depression. Biol. Psychiatry 2000, 48:70-74.
54. Young E.A., Vazquez D., Jiang H., Pfeffer C.R. Saliva cortisol and response to dexamethasone in children of depressed parents. Biol. Psychiatry 2006, 60:831-836.